Attenuated BMP1 function in humans leads to osteogenesis imperfecta (OI), a disease involving impaired fibrillogenesis of collagen, which otherwise is frequently caused by dominant mutations in α1(I) or α2(I)32–34. This evidence concerns the gene BMP1 and osteogenesis imperfecta.